312 related articles for article (PubMed ID: 28005986)
1. A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted.
Neumann PJ; Thorat T; Zhong Y; Anderson J; Farquhar M; Salem M; Sandberg E; Saret CJ; Wilkinson C; Cohen JT
PLoS One; 2016; 11(12):e0168512. PubMed ID: 28005986
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
[TBL] [Abstract][Full Text] [Related]
4. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies.
Leech AA; Kim DD; Cohen JT; Neumann PJ
Value Health; 2018 Jul; 21(7):759-761. PubMed ID: 30005746
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
[TBL] [Abstract][Full Text] [Related]
6. Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures.
Neumann PJ; Anderson JE; Panzer AD; Pope EF; D'Cruz BN; Kim DD; Cohen JT
Gates Open Res; 2018; 2():5. PubMed ID: 29431169
[No Abstract] [Full Text] [Related]
7. Cost-Effectiveness of Exploratory Laparotomy in a Regional Referral Hospital in Eastern Uganda.
Bellamkonda N; Motwani G; Wange AH; De Boer C; Kirya F; Juillard C; Marseille E; Ajiko MM; Dicker RA
J Surg Res; 2020 Jan; 245():587-592. PubMed ID: 31499364
[TBL] [Abstract][Full Text] [Related]
8. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.
Kuznik A; Habib AG; Munube D; Lamorde M
BMC Health Serv Res; 2016 Jul; 16():304. PubMed ID: 27461265
[TBL] [Abstract][Full Text] [Related]
9. Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries.
Marseille E; Jiwani A; Raut A; Verguet S; Walson J; Kahn JG
BMJ Open; 2014 Jun; 4(6):e003987. PubMed ID: 24969782
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of interventions for HIV/AIDS, malaria, syphilis, and tuberculosis in 128 countries: a meta-regression analysis.
Silke F; Earl L; Hsu J; Janko MM; Joffe J; Memetova A; Michael D; Zheng P; Aravkin A; Murray CJL; Weaver MR
Lancet Glob Health; 2024 Jul; 12(7):e1159-e1173. PubMed ID: 38876762
[TBL] [Abstract][Full Text] [Related]
11. [Cost-effectiveness of public health practices: a literature review of public health interventions from the Mesoamerican Health Initiative].
Valencia-Mendoza A; Danese-dlSantos LG; Sosa-Rubí SG; Aracena-Genao B
Salud Publica Mex; 2011; 53 Suppl 3():S375-85. PubMed ID: 22344382
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries.
Hogan DR; Baltussen R; Hayashi C; Lauer JA; Salomon JA
BMJ; 2005 Dec; 331(7530):1431-7. PubMed ID: 16282380
[TBL] [Abstract][Full Text] [Related]
13. The burden of Neglected Tropical Diseases in Brazil, 1990-2016: A subnational analysis from the Global Burden of Disease Study 2016.
Martins-Melo FR; Carneiro M; Ramos AN; Heukelbach J; Ribeiro ALP; Werneck GL
PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006559. PubMed ID: 29864133
[TBL] [Abstract][Full Text] [Related]
14. Orthopaedic trauma care in Haiti: a cost-effectiveness analysis of an innovative surgical residency program.
Carlson LC; Slobogean GP; Pollak AN
Value Health; 2012; 15(6):887-93. PubMed ID: 22999139
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of health systems strengthening interventions in improving maternal and child health in low- and middle-income countries: a systematic review.
Zeng W; Li G; Ahn H; Nguyen HTH; Shepard DS; Nair D
Health Policy Plan; 2018 Mar; 33(2):283-297. PubMed ID: 29253136
[TBL] [Abstract][Full Text] [Related]
16. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
17. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF
BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802
[TBL] [Abstract][Full Text] [Related]
19. Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review.
Oostvogels AJ; De Wit GA; Jahn B; Cassini A; Colzani E; De Waure C; Kretzschmar ME; Siebert U; Mühlberger N; Mangen MJ
Epidemiol Infect; 2015 Jul; 143(9):1791-802. PubMed ID: 25499823
[TBL] [Abstract][Full Text] [Related]
20. Cost Per DALY Averted in a Surgical Unit of a Private Hospital in India.
Chatterjee S; Laxminarayan R; Gosselin RA
World J Surg; 2016 May; 40(5):1034-40. PubMed ID: 26675929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
